As of 2025-07-21, the Fair Value of Adial Pharmaceuticals Inc (ADIL) is -2.84 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.45 USD, the upside of Adial Pharmaceuticals Inc is -728.50%.
With the market price of 0.45 USD and our fair value calculation, Adial Pharmaceuticals Inc (ADIL) is not a good investment. Investing in ADIL stocks now will result in a potential loss of 728.50%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -10.89 | -19.42 | -12.73 | -5.12 | -13.20 | -12.27 |
| YoY growth | -26.78% | -78.33% | 34.45% | 59.75% | -157.59% | -33.70% |
| Market Cap (mil) | 7.12 |
| P/E | |
| Forward P/E |
| EPS | -0.57 |
| Avg earnings growth rate | -33.70% |
| TTM earnings | -8.95 |